Perspectives

Tailored Treatment Algorithms, Liquid Biopsy and Personalized Medicine
In this fifth episode, Joel sits down with Brian Leyland-Jones, MB BS, PhD, CMO, National Foundation for Cancer Research and Peter Kuhn, PhD, Dean’s Professor of Biological Sciences, Professor of Biological Sciences, Medicine, Biomedical Engineering, Aerospace and Mechanical Engineering and Urology
Podcast Sep 8, 2022
ACT Now, or Flop Later (Though Sooner Than You Might Expect)
With the latest market correction bringing an unprecedented proportion of publicly-traded Biotechs into the realm of negative enterprise value, an increasing number of management teams are being confronted with the existential question of whether and how they might maneuver out of the muck to higher, dryer ground.
View Aug 25, 2022